Arch Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q3 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Arch Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2011 to Q2 2024.
  • Arch Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 4.44M shares, a 246% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 4.44M +3.16M +246% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 4.44M +3.17M +249% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 4.74M +3.49M +280% Dec 31, 2023 10-Q 2024-02-20
Q3 2023 4.69M +3.44M +274% Sep 30, 2023 10-Q 2024-08-19
Q2 2023 1.29M -236M -99.5% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 1.27M -236M -99.5% Mar 31, 2023 10-Q 2023-05-23
Q4 2022 1.25M -236M -99.5% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 1.25M -235M -99.5% Sep 30, 2022 10-K 2024-02-15
Q2 2022 237M +275K +0.12% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 237M +350K +0.15% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 237M +43.9M +22.7% Dec 31, 2021 10-Q 2022-02-11
Q3 2021 237M +43.7M +22.6% Sep 30, 2021 10-K 2022-12-28
Q2 2021 237M +41.1M +21% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 237M +48.9M +26% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 193M +5.23M +2.79% Dec 31, 2020 10-Q 2021-02-12
Q3 2020 193M +19.5M +11.2% Sep 30, 2020 10-K 2021-12-17
Q2 2020 196M +22M +12.7% Jun 30, 2020 10-Q 2020-07-23
Q1 2020 188M +22.9M +13.9% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 188M +22.9M +13.9% Dec 31, 2019 10-Q 2020-01-30
Q3 2019 174M +9.18M +5.58% Sep 30, 2019 10-K 2020-12-11
Q2 2019 174M +19.5M +12.7% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 165M +10.9M +7.08% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 165M +10.9M +7.08% Dec 31, 2018 10-Q 2019-02-01
Q3 2018 164M +10.7M +6.97% Sep 30, 2018 10-K 2019-11-19
Q2 2018 154M +3.28M +2.18% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 154M +3.28M +2.18% Mar 31, 2018 10-Q 2018-04-26
Q4 2017 154M +15.9M +11.5% Dec 31, 2017 10-Q 2018-02-01
Q3 2017 154M +17M +12.5% Sep 30, 2017 10-K 2018-12-18
Q2 2017 151M +17.7M +13.3% Jun 30, 2017 10-Q 2017-07-27
Q1 2017 151M +40.3M +36.5% Mar 31, 2017 10-Q 2017-05-02
Q4 2016 138M +29M +26.6% Dec 31, 2016 10-Q 2017-02-01
Q3 2016 137M +29.1M +27% Sep 30, 2016 10-K 2017-11-15
Q2 2016 133M +40.3M +43.5% Jun 30, 2016 10-Q 2016-07-28
Q1 2016 110M +34.3M +45.1% Mar 31, 2016 10-Q 2016-04-28
Q4 2015 109M +33.1M +43.5% Dec 31, 2015 10-Q 2016-02-12
Q3 2015 108M +35.5M +49.3% Sep 30, 2015 10-K 2016-12-05
Q2 2015 92.7M +20.6M +28.6% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 76.1M +4.15M +5.77% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 76.1M +15.9M +26.5% Dec 31, 2014 10-Q 2015-02-09
Q3 2014 72.1M +11.9M +19.8% Sep 30, 2014 10-K 2015-12-11
Q2 2014 72.1M +13.4M +22.9% Jun 30, 2014 10-Q 2014-08-06
Q1 2014 71.9M +65.9M +1093% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 60.1M +54.1M +897% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 60.1M +54.5M +965% Sep 30, 2013 10-K 2014-12-12
Q2 2013 58.6M +54.6M +1366% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 6.03M Mar 31, 2013 10-Q 2013-05-20
Q4 2012 6.03M Dec 31, 2012 10-Q 2013-02-14
Q3 2012 5.65M +1.65M +41.1% Sep 30, 2012 10-K/A 2014-05-01
Q2 2012 4M Jun 30, 2012 10-Q 2012-08-14
Q3 2011 4M Sep 30, 2011 10-K 2012-12-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.